KB

Kiran Babulal Gandhi

Director Additional Director DIN 01663273
DIN 01663273 First appointment Aug 2007 Primary industry Agriculture
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Aug 2007
Shareholding value β€’β€’β€’β€’ Premium profile

About Kiran Babulal Gandhi

Data last updated:

Kiran Babulal Gandhi was an Additional Director at Karyotica Biologicals Private Limited (2023) and Director at Shri Gbs Biotech Private Limited (from 2007). The companies operate in Agriculture.

DIN 01663273
Primary Designation Additional Director
Industry Agriculture
First Appointment 16 Aug 2007
Oldest Company Age 19 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Additional Director11 Apr 20232012₹12.87 Cr (FY 2025)Active
Shri Gbs Biotech Private Limited U01403TG2007PTC055140
Director16 Aug 20072007Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Shri Gbs Biotech Private Limited
Karyotica Biologicals Private Limited
Premium access

Shareholding and investment profile for Kiran Babulal Gandhi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kiran Babulal Gandhi

Kiran Babulal Gandhi was first appointed on 16 Aug 2007 as Director at Shri Gbs Biotech Private Limited. The most recent appointment on record is 11 Apr 2023 at Karyotica Biologicals Private Limited.

Kiran Babulal Gandhi held 2 earlier board appointments: Karyotica Biologicals Private Limited (Additional Director, 11 Apr 2023 to 15 Sep 2023); Shri Gbs Biotech Private Limited (Director, from 16 Aug 2007).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available